1. Amakusa T, Iizuka R, Kuruma I, Uto M. Transfer to cerebrospinal fluid of aniracetam in cerebrovascular disease. Journal of Clinical Therapeutics and Medicines (Japan) 3: 381–392, 1987
2. Bandle E. Studies on the metabolism of 2 14C-labelled forms /002 and /004 of the cerebral insufficiency improver Ro 13-5057 in the rat. F. Hoffmann-La Roche (Basle), data on file, B-94’874, May 13, 1980
3. Bandle EF, Wendt G, Ranalder UB, Trautmann K-H. 2-Pyrrolidinone and succinimide endogenously present in several mammalian species. Life Sciences 35: 2205–2212, 1984
4. Brandt R, Meyer H. Binding of Ro 13-5057 and of its pyrrolidinone metabolite to human plasma proteins. F. Hoffmann-La Roche (Basle), data on file, B-84’787, December 20, 1982
5. Calder III WA. Size, function, and life history, p. 112, Harvard University Press, Massachusetts, 1984